The leading representative office of defined VC is situated in the Hong Kong. The company was established in Asia in Hong Kong.
Deals in the range of 50 - 100 millions dollars are the general things for fund. The top activity for fund was in 2019. The fund is constantly included in 2-6 deals per year.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Tybourne Capital Management, startups are often financed by Kairos Ventures, Visa, Sumitomo Mitsui Trust Bank. The meaningful sponsors for the fund in investment in the same round are Temasek Holdings, Spruce Capital Partners, Soros Capital Management.
Among the various public portfolio startups of the fund, we may underline Paidy, Provivi The fund has no specific favorite in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Agriculture, FinTech. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - Japan.
Related Funds
Funds with similar focus
Fund Name | Location |
1982 Ventures | - |
Audible | New Jersey, Newark, United States |
BCD Travel | Netherlands, Utrecht, Utrecht |
Brain Corp | California, San Diego, United States |
Fashion 22 | - |
Global Alliance for Genomics & Health | Canada, Ontario, Toronto |
Jane VC | Boston, Massachusetts, United States |
Metropolitan Venture Partners | New York, New York, United States |
MIA Investment Limited | Dorset, Poole, United Kingdom |
Optimist Capital | - |
Saiyi Industry Fund | - |
SeedersClub | Bangkok, Krung Thep, Thailand |
SG Gestion | France, Ile-de-France, Paris |
Technology Development Fund | Gullbringusysla, Iceland, Reykjavík |
The Grosvenor Funds | District of Columbia, United States, Washington |
Total Sport and Entertainment | Australia, Crows Nest, Queensland |
U.S. Department of Energy Advanced Manufacturing Office | District of Columbia, United States, Washington |
VANTEC Angel Network | British Columbia, Canada, Vancouver |
Wadhawan Global Capital | India, Maharashtra, Mumbai |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
CADDi | $72M | 23 Aug 2021 | Chiyoda, Japan | ||
Zentera Therapeutics | $75M | 04 Aug 2021 | Shanghai, Shanghai, China | ||
$45M | 22 Dec 2020 | Santa Monica, California, United States | |||
Zentera Therapeutics | $20M | 21 May 2020 | Shanghai, Shanghai, China | ||
Paidy | $83M | 01 Nov 2019 | Chiba Prefecture | ||
$85M | 15 Oct 2019 | Santa Monica, California, United States | |||
CarDekho | $110M | 03 Jan 2019 | Gurugram, Haryana, India | ||
Bicycle Therapeutics | $27M | 01 Dec 2018 | England | ||
FreeCharge | $80M | 05 Feb 2015 | India, Maharashtra |
– CADDi, a B2B ordering and supply platform in the manufacturing and procurement industry, raised $73m in Series B funding.
– The round was led by Globis Capital Partners and World Innovation Lab (WiL), with participation from existing investors DCM and Global Brain.
– Six new investors also joined the round including Arena Holdings, DST Global, Minerva Growth Partners, Tybourne Capital Management, JAFCO Group and SBI Investment.
– The post-money valuation is estimated at $450m.
– The funding proceeds will be used for accelerating digital transformation of the platform, hiring and expanding to global markets.
– Zentera Therapeutics, a Shanghai, China-based clinical-stage biopharmaceutical company, raised $75M in Series B funding.
– The round was led by OrbiMed Advisors Asia and Tybourne Capital Management with participation from Avidity Partners, Casdin Capital, Surveyor Capital, Farallon Capital Management, Lilly Asia Ventures, Logos Capital, Perceptive Advisors, Redmile Group and Viking Global Investors.
– The company intends to use the funds to advance the development of three Zentalis-discovered oncology clinical candidates as well as business development for future pipeline additions in China.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
CADDi | $72M | 23 Aug 2021 | Chiyoda, Japan | ||
Zentera Therapeutics | $75M | 04 Aug 2021 | Shanghai, Shanghai, China | ||
$45M | 22 Dec 2020 | Santa Monica, California, United States | |||
Zentera Therapeutics | $20M | 21 May 2020 | Shanghai, Shanghai, China | ||
Paidy | $83M | 01 Nov 2019 | Chiba Prefecture | ||
$85M | 15 Oct 2019 | Santa Monica, California, United States | |||
CarDekho | $110M | 03 Jan 2019 | Gurugram, Haryana, India | ||
Bicycle Therapeutics | $27M | 01 Dec 2018 | England | ||
FreeCharge | $80M | 05 Feb 2015 | India, Maharashtra |